Clinical Trial Update: Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the tolerability of duloxetine in patients with major depressive disorder and Parkinson's disease; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder, Idiopathic Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2010-08-16